Cellvizio System

System Page.png

Introducing the Next-Generation Cellvizio®, Real-Time In Vivo Cellular Imaging Platform

Built with enhanced capabilities, this entirely new system uses Confocal Laser Endomicroscopy (CLE) advanced imaging technology to deliver cellular visualization virtually anywhere in the human body.

Cellvizio lets you see precisely what’s occurring in the human body, at the cellular level in real time. It’s visibility on a micro level, with macro potential to transform patient management and care. Next-generation Cellvizio pushes the boundaries of interventional medicine, and creates the unique opportunity to monitor, assess, classify, and guide the diagnosis and care of various diseases and cancers like never before.

The Cellvizio Platform combines a Laser Scanning Unit and a processor utilizing proprietary software. It is used with a range of flexible Confocal MiniprobesTM.

Next-Gen Probes.png

The system architecture is built with enhanced capabilities including small footprint, optimized integration into procedure rooms, and is easy to maneuver and use.

Picture-in-Picture (PiP) enables optimized integration into endoscopic, bronchoscopic, or operating environments, with DICOM connectivity for patient data sharing, retrieval, review, and archiving.

Intuitive and responsive touch-screen interface and single-handed probe connection for quick startup.

The Cellvizio flexible Confocal Miniprobes are inserted into the operating channel of any endoscope, much like the manner in which biopsy forceps are used.

They are compatible with standard reprocessing methods.

A wide range of probes is available for a variety of medical applications in gastroenterology, pulmonology and urology.

Probes circle.png

Confocal Imaging: Cellvizio Images come from a thin focal plane that is optically projected into the tissue. This provides a deep observation of the mucosa and what is happening in the cells in real time.

CLE Technology EN.png

Cellvizio Service Contract

Mauna Kea Technologies offers service contracts that are tailored to your needs and designed to maintain and ensure continuous support of your Cellvizio system.

Our goal is to optimize the productivity of your system to ensure a continuity of care to your patients.

This includes:

  • Preventative maintenance
  • Regular software upgrades
  • On-site maintenance
  • Loaner Service
  • Log files-based predictive maintenance
  • On-demand support

Experiencing a technical problem?

A simple phone call or email is all it takes. Our service teams can immediately analyze the problem and run diagnostic tests through an efficient remote service.

US: +1 (888) 590-1798
Europe: +33 1 70 08 09 67

Cellvizio® I.V.E. with Confocal MiniprobesTM are regulated Medical Devices, CE marked (CE 0459) (Class IIa - NB :G-MED) and FDA cleared. Cellvizio® is a registered trademark and Confocal MiniprobeTM is a trademark of Mauna Kea Technologies. Cellvizio® I.V.E. with Confocal MiniprobesTM are confocal laser systems with fiber optic probes that are intended to allow imaging of the internal microstructure of tissues including, but not limited to, the identification of cells and vessels and their organization or architecture. These statements and the associated reference to specific clinical studies, are not intended to represent claims of safety or effectiveness for detecting or treating any specific condition or disease state. Rather this information is intended to provide useful reference to selected published literature describing physician experiences with the associated clinical uses. Any diagnostic assessment should always be made by the attending physician, based on the evaluation of all sources of clinical, endoscopic and other relevant information. These statements have not been reviewed, cleared, or approved by the U.S. FDA. The use of this medical device is exclusively reserved for healthcare professionals.

Find out more by downloading the
Cellvizio Brochure